Srividya Neelakantan

2PUBLICATIONS
11CO-AUTHORS
Innate immunityGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Mar 11, 2025
Japanese Phase 1 Study for Global Development of Anti-TL1A Antibody PF-06480605: A Randomized, Placebo-Controlled, Single-Ascending Dose Study.

Kei Fukuhara, Srividya Neelakantan, Kenichi Furihata

|Nov 05, 2021
Dystrophin and mini-dystrophin quantification by mass spectrometry in skeletal muscle for gene therapy development in Duchenne muscular dystrophy.

Vahid Farrokhi, Jason Walsh, Joe Palandra

Pageof 1

Frequent Collaborators

1 joint publications

Vahid Farrokhi

1 joint publications

Jason Walsh

1 joint publications

Joanne Brodfuehrer

1 joint publications

Teresa Caiazzo

1 joint publications

Florence Yong

1 joint publications

Hendrik Neubert

1 joint publications

Kei Fukuhara

1 joint publications

Kenichi Furihata

1 joint publications

Hirotoshi Yuasa

1 joint publications

Nanzhi Shi

Frequent Collaborators

1 joint publications

Vahid Farrokhi

1 joint publications

Jason Walsh

1 joint publications

Joanne Brodfuehrer

1 joint publications

Teresa Caiazzo

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
06:37

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on : Sep 15, 2023

508
Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
05:16

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on : May 07, 2020

7.0K
See more related videos

Top Related Videos

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
06:37

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on : Sep 15, 2023

508
Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
05:16

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on : May 07, 2020

7.0K
See more related videos